¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Cleavage Stimulation Factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢º´À¯¹ßÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dilution factor
Èñ¼®ÀÎÀÚ
exclusion of confounding factor
±³¶õ¹èÁ¦ÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
extrinsic factor
¿ÜÀÎÀÎÀÚ, ¿ÜÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇÇÀ¯·¡¼öÃàÀÎÀÚ
endothelium-derived relaxing factor
³»ÇÇÀ¯·¡ÀÌ¿ÏÀÎÀÚ
endurance factor
°ßµõÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
fermentation factor
¹ßÈ¿ÀÎÀÚ
fertility factor
¼öÅÂÀÎÀÚ
fibrin stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
corticotropin releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢À¯¹ßÀÎÀÚ
dilution factor
¹±ÈûÀÎÀÚ, Èñ¼®ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇǼ¼Æ÷¼öÃàÀÎÀÚ
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷ÀÌ¿ÏÀÎÀÚ
endurance factor
Áö¼ÓÀÎÀÚ
eosinophil chemotactic factor
È£»ê±¸ÈÇÐÁÖ¼ºÀÎÀÚ, È£»ê±¸ÈÇнò¸²ÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
Stuart-Prower factor
½ºÆ©¾îÆ®-ÇÁ¶ó¿ö ÀÎÀÚ
T cell activating factor
T¼¼Æ÷Ȱ¼ºÀÎÀÚ
T cell factor (TCF)
T¼¼Æ÷
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
T cell replacing factor
T¼¼Æ÷ ´ëüÀÎÀÚ
T-cell growth factor
T-¼¼Æ÷¼ºÀåÀÎÀÚ
TGF => transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
TNF => tumor necrosis factor
Á¾¾ç±«»çÀÎÀÚ
TRF=£¾thyrotrophin releasing factor
°©»ó¼±ÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
TRF=£¾thyrotrophin releasing factor
°©»ó¼±ÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ.
V factor
V ÀÎÀÚ
V-factor
VÀÎÀÚ
Willebrand factor
ºô·¹ºê¶õÆ®ÀÎÀÚ
X factor
X ÀÎÀÚ
X-factor
XÀÎÀÚ, Ç츶ƾ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
lines of cleavage
ÇǺÎÇÒ¼±(ù«Ý±ùÜàÊ)
meridional cleavage
¼¼·ÎºÐÇÒ(¡ÝÂùÜ), °æ¼±ºÐÇÒ(ÌèàÊÝÂùÜ).
meridional cleavage plane
³¯ÁÙºÐÇÒ¸é
meroblastic cleavage
±¹¹è¼º ºÐÇÒ(ÏÑÛÏàõÝÂùÜ).
meroblastic cleavage
ºÎºÐºÐÇÒ
mosaic cleavage
¸ðÀÚÀÌÅ©¼º ³ÇÒ(¡àõÕ°ùÜ).
partial cleavage ³ª segmentatio partialis
ºÎºÐºÐÇÒ(Ý»ÝÂÝÂùÜ).
radial cleavage
ºÎê»ìºÐÇÒ
right spiral cleavage
¿À¸¥³ª¼±ºÐÇÒ
spiral cleavage
³ª¼±³ÇÒ(¡Õ°ùÜ).
spiral cleavage
³ª¼±ºÐÇÒ
superficial cleavage
Ç¥ÃþºÐÇÒ
surface cleavage
Ç¥ÇǺÐÇÒ(øúù«ÝÂùÜ).
unequal cleavage
ºÒ±ÕµîºÐÇÒ
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½